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Introduction:
Phospholipid transfer protein (PLTP) plays an important role in the metabolism of lipoproteins (Tall and Lalanne, 2003) and belongs to the family of lipid transfer/lipopolysaccharide-binding proteins, including cholesteryl ester transfer protein (CETP), lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) (Tollefson et al., 1988; Day et al., 1994) . It has been shown that PLTP facilitates the transfer and exchange of phospholipids between VLDL and HDL (Tall et al., 1985) . Several clinical studies suggest that high plasma PLTP activity is a risk factor for coronary artery disease and a determinant of carotid intima-media thickness in type 2 diabetes mellitus (Schlitt et al., 2003; de Vries et al., 2006) . Studies employing genetically modified mice strongly suggest that PLTP functions as a pro-atherogenic factor (Jiang et al., 2001; van Haperen et al., 2002; Yang et al., 2003) . Deletion of PLTP in hyperlipidemic apoE deficient and human apoB transgenic mouse strains results in reduced LDL and atherosclerotic lesion areas (Jiang et al., 2001 ). Overexpression of PLTP in hyperlipidemic mouse models increased susceptibility to atherosclerosis (van Haperen et al., 2002; Yang et al., 2003; Samyn et al., 2008; van Haperen et al., 2008) .
In addition to its function in the circulation, intracellular PLTP has been shown to regulate apoB containing lipoprotein secretion in murine hepatocytes (Jiang et al., 2001 ).
PLTP deficiency reduces apoB secretion from mouse primary hepatocytes. Microsomal triglyceride transfer protein (MTP) is required for the assembly of apoB-lipoproteins and secretion (Hussain et al., 2003) . Inhibition of MTP nearly abolished apoB secretion and apoB containing lipoprotein production (Jamil et al., 1996; Jamil et al., 1998; Chandler et al., 2003) . MTP has been reported to transfer not only triglyceride, but also phospholipids This article has not been copyedited and formatted. The final version may differ from this version. (Athar et al., 2004; Rava et al., 2005) . However, there is no homology between MTP and PLTP at gene or protein sequence levels. MTP and apoB belong to the vitellogenin (VTG) family of lipid transfer proteins. Read et al predicted the three dimensional structure of the C-terminal lipid binding cavity of MTP based on the crystal structure of lipoviellin (Read et al., 2000) . It has been implied that these binding sites may be responsible for triglyceride and phospholipid transport in MTP (Jamil et al., 1996; Read et al., 2000) . PLTP and MTP may work sequentially to regulate the assembly and secretion of apoB-containing lipoproteins (Jiang et al., 2005) .
We recently reported the identification of small molecule inhibitors that selectively inhibit phospholipid transfer activity of PLTP (Luo et al., 2009) . We found that specific inhibition of PLTP activity reduces the secretion of apoB from human hepatoma cells and mouse primary hepatocytes. Here we report the identification of compounds that inhibit both MTP and PLTP. These compounds markedly reduced apoB secretion from hepatocytes.
This article has not been copyedited and formatted. The final version may differ from this version. PLTP activity assay: PLTP activity was measured as described previously (Luo et al., 2009 Vesicles were subsequently precipitated with a MnCl2/heparin solution and the radioactivity of the supernatant was measured on a Wallac Microbeta scintillation counter. Non-specific transfer wells (-PLTP) were included for background subtraction.
Transfer rate was calculated as [[(total dpm -background dpm) * 3.5] / specific activity (dpm/nmol) / assay time (hours)].
MTP activity assay: MTP activity was measured as described previously (Chandler et al., 2003) ; with minor modification. Human microsomes purchased from Sigma (M0567)
were extracted as described by Haghpassand et al to obtain soluble MTP protein (Haghpassand et al., 1996) . Solubilized MTP protein was dialyzed and used as source for MTP activity. Donor and acceptor liposomes were prepared as described (Haghpassand et al., 1996) . Donor liposomes were prepared by bath sonication of a mixture containing 447 µM egg phosphatidylcholine, 83 µM bovine heart cardiolipin, and 0. Microsomal triglyceride transfer protein (MTP) is an important intracellular lipid transfer protein that regulates apoB secretion (Athar et al., 2004 , Jamil, 1996 Rava et al., 2005) . Even though MTP has no homology with PLTP at the protein sequence level, we analyzed the selectivity of the PLTP inhibitors against MTP activity since both proteins regulate apoB secretion. We tested these compounds for their effects on MTP mediated triglyceride transfer activity. The PLTP inhibitors demonstrated differential effects on MTP activity (Luo et al., 2009) (Figure 3 and Table 1 ). Unlike compound A, which is selective for PLTP (Luo et al., 2009) 
Effects of PLTP inhibitors on apoB secretion in human hepatoma cells:
The PLTP gene is highly expressed in the human hepatoma cell lines, HepG2 and Huh7 (Luo et al., 2009 ).
We analyzed the effects of the dual inhibitors on apoB secretion in HepG2 and Huh7 cells (Figure 4a and 4c). These compounds had no significant effect on transferrin secretion which was used to normalize the secretion of apoB (Figure 4b ), except compound G at 30μM decreased transferrin (P<0.05). None of the compounds at 30μΜ altered cellular PLTP protein expression (data not shown), confirming that the effects of these compounds on apoB secretion were mediated through reducing PLTP activity not PLTP protein. ApoB secretion was normalized to secreted transferrin in order to rule out any variations including compound mediated effects on protein secretion and cell number due to cytotoxicity or seeding. HepG2 and Huh7 showed a similar response to compound treatment. Both Compound F and G at 30μM suppressed apoB secretion by 60% and 80%, respectively. Compound G is a more potent PLTP inhibitor than compound F while they both equally inhibit MTP activity. Compound G at 3 μM reduced apoB secretion to a similar level (-50%) as compound F at 30 μM in HepG2 cells (Figure 4a ), implying that PLTP inhibition may contribute to the difference. Similar effects were observed in Huh7 cells (Figure 4b) . Furthermore, compound H, which is selective for MTP with an in vitro IC50 of 8uM, had no effect on apoB secretion at 10μΜ (Figure 4a The inhibitory effect of compound G on MTP led to more marked reduction of apoB secretion than compound A (Figure 4a ). These data suggest that dual inhibition of both PLTP and MTP had an additive effect on the reduction of apoB secretion.
Inhibition of MTP reduces both apoB and triglyceride secretion (Jamil et al., 1996; Chandler et al., 2003) . We have previously shown that a PLTP-selective inhibitor did not reduce triglyceride secretion in HepG2 cells (Luo et al., 2009 ). Here we confirmed that We recently reported studies characterizing small molecule inhibitors that selectively inhibit PLTP activity and concomitantly reduce apoB secretion. In the present study, we identified small molecules that inhibit both PLTP and MTP activities, which are known to regulate apoB secretion. This is the first report to identify dual inhibitors for PLTP and MTP activities. The discovery was not expected based on the lack of homology of PLTP and MTP at protein sequence levels. Although CETP and PLTP have 40% homology and belong to the family of lipid transfer/lipopolysaccharide-binding proteins (Tollefson et al., 1988; Day et al., 1994) , none of these compounds inhibits CETP activity (Luo et al., 2009 ). MTP and apoB belong to the vitellogenin (VTG) family of lipid transfer proteins.
Read et al predicted the three dimensional structure of the C-terminal lipid binding cavity of MTP based on the crystal structure of lipoviellin (Read et al., 2000) . The lipid cavity in MTP bears a resemblance to the lipid binding domain of BPI, suggesting that PLTP and MTP have similar lipid binding cavities where the dual inhibitors could potentially bind. It has been implied that these binding sites may be responsible for triglyceride and phospholipid transport in MTP (Jamil et al., 1996; Read et al., 2000) . Compound G is ten times more potent in inhibiting PLTP than inhibiting MTP, however its enantiomer, compound H, is selective for MTP, and is essentially inactive in inhibiting PLTP, suggesting that the inhibitory effect is specific, and is unlikely caused by non-specific Dual inhibitors appear to have additive effects in reducing apoB secretion in hepatoma cells, implying that MTP and PLTP contribute to apoB-containing lipoprotein assembly at different steps. MTP transfers triglyceride to nascent apoB in endoplasmic reticulum and stabilize apoB containing particles for secretion (Jamil et al., 1996; Jamil et al., 1998) . A number of MTP inhibitors have been reported and characterized. The MTP inhibitors are very potent in inhibiting triglyceride transfer activity of MTP, however, they have little effect on the phospholipid transfer activity of MTP (Jamil et al., 1996; Jamil et al., 1998; Chandler et al., 2003) . It has been shown that phospholipid transfer activity of MTP plays a role in the assembly and secretion of apoB containing lipoproteins (Rava et al., 2005; Rava et al., 2006) . Although the mechanisms of PLTP regulation of apoB secretion are not well understood, we speculate that PLTP may participate in the second step of apoB-containing particle formation, i.e. the addition of more phospholipids to the nascent VLDL particle in Golgi (Hamilton et al., 1998) , where significant PLTP activity is present and considerable phospholipids are synthesized (Fang et al., 1998) . Detailed understanding of the mechanism of PLTP deserves further investigation.
Compound F and compound G are structurally similar and had similar activity on MTP, but compound G is five times more active in inhibiting PLTP than compound F and is more potent in reducing apoB secretion (Table 1 and Figure 4a ). These results indicate that the more potent PLTP inhibitory activity of compound G may contribute the difference. However, one could argue that the differential effect could be due to the 
